Antigenix Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8.35M

  • Investors
  • 6

Antigenix Therapeutics General Information

Description

Developer of a platform designed to create antibody-based therapies that precisely target cancer cells while sparing healthy tissue. The company offers monoclonal antibodies directed at novel, tumor-specific targets, enabling cancer patients with high unmet needs to receive safer and more effective treatment options.

Contact Information

Website
www.antigenixthera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Princeton Biolabs
  • 303A College Road East
  • Princeton, NJ 08540
  • United States
+1 (317)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Princeton Biolabs
  • 303A College Road East
  • Princeton, NJ 08540
  • United States
+1 (317)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antigenix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 18-Nov-2025 $8.35M Completed Pre-Clinical Trials
1. Spin-Off 01-Jan-2024 Completed Pre-Clinical Trials
To view Antigenix Therapeutics’s complete valuation and funding history, request access »

Antigenix Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-1
To view Antigenix Therapeutics’s complete cap table history, request access »

Antigenix Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antigenix Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioCrossroads Venture Capital Minority
Kastor Capital Venture Capital Minority
New Jersey Economic Development Authority Government Minority
Pier 70 Ventures Venture Capital Minority
T-REX Accelerator/Incubator Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Antigenix Therapeutics FAQs

  • When was Antigenix Therapeutics founded?

    Antigenix Therapeutics was founded in 2024.

  • Where is Antigenix Therapeutics headquartered?

    Antigenix Therapeutics is headquartered in Princeton, NJ.

  • What is the size of Antigenix Therapeutics?

    Antigenix Therapeutics has 4 total employees.

  • What industry is Antigenix Therapeutics in?

    Antigenix Therapeutics’s primary industry is Drug Discovery.

  • Is Antigenix Therapeutics a private or public company?

    Antigenix Therapeutics is a Private company.

  • What is the current valuation of Antigenix Therapeutics?

    The current valuation of Antigenix Therapeutics is .

  • What is Antigenix Therapeutics’s current revenue?

    The current revenue for Antigenix Therapeutics is .

  • How much funding has Antigenix Therapeutics raised over time?

    Antigenix Therapeutics has raised $8.35M.

  • Who are Antigenix Therapeutics’s investors?

    BioCrossroads, Kastor Capital, New Jersey Economic Development Authority, Pier 70 Ventures, and T-REX are 5 of 6 investors who have invested in Antigenix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process